National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Search
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Clinical Trial Results

Summaries of Newsworthy Clinical Trial Results

< Back to Main

Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Browse by Cancer Type
Breast Cancer

Lung Cancer

Prostate Cancer

More Results
Search Trial Results

    Search  
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

NIH Calendar of Events
Scientific meetings

Español
Información en español
NCI Highlights
Imiquimod May Help to Prevent Vulvar Cancer

Sorafenib Increases Risk of High Blood Pressure

Past Highlights
HPV Vaccines for Cervical Cancer
Related Pages
Clinical Trial Search
NCI's PDQ® registry of cancer clinical trials.

Testicular Cancer Home Page
NCI's gateway for information about testicular cancer.
Testicular Cancer Trial Results
1.  Fewer CT Scans Needed after Surgery for Low-Risk, Early-Stage Testicular Cancer
(Posted: 06/28/2006, Reviewed: 04/17/2007) - During the follow-up period after surgery, two computed tomography (CT) scans were just as effective as five CT scans in detecting relapse for patients with a certain kind of low-risk, early-stage testicular cancer, according to findings presented at the 2006 meeting of the American Society of Clinical Oncology.

2.  Carboplatin May Be Less Toxic Than Radiation for Seminoma
(Posted: 06/07/2004, Updated: 08/03/2005) - One shot of carboplatin appeared to be as effective as radiation therapy in treating early seminoma, a kind of testicular cancer, and also appeared safer, reducing the risk of second cancers, according to the July 23, 2005, issue of the Lancet. Further follow-up is needed to show whether the benefits continue.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov